Evidence map›Paper›PMID 39531122›Full record

ReviewInternational ophthalmology2024

Review on classification of polypoidal choroidal vasculopathy.

Wenfei Zhang, Youxin Chen

Abstract readReview
PubMed Publisher
In one paragraph

Review in International ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pachychoroid diseases of the macula: an update.Medical hypothesis, discovery & innovation ophthalmology journal · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wenfei ZhangDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Youxin ChenDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. chenyx@pumch.cn.

Funding

National Natural Science Foundation of China 82271112
6 · The paper itself

Abstract

backgroundPolypoidal choroidal vasculopathy (PCV) is a complex vascular disorder characterized by a branching neovascular network with polypoidal lesions at its termini. Despite extensive research, the etiology and pathogenesis of PCV remain inadequately understood, and the condition exhibits significant clinical and pathological heterogeneity. In recent years, numerous studies have identified potential subtypes within PCV and proposed various classification schemes. However, a universally accepted classification system for PCV has yet to be established. PURPOSE: This review aims to provide a comprehensive overview of the different classification methods for PCV that have emerged alongside advancements in imaging technologies and a deeper understanding of PCV, highlighting their clinical relevance and prognostic implications.

methodsA systematic search of PubMed, Embase, Web of Science, and Cochrane databases was conducted. Literature management was facilitated using EndNote X9 software.

resultsBy synthesizing existing classification approaches, this paper seeks to offer a clearer understanding of PCV subtypes, which may guide future research and inform treatment strategies.

Indexed as

ChoroidChoroidal NeovascularizationFluorescein AngiographyPolypsChoroid DiseasesFundus OculiHumansPolypoidal Choroidal VasculopathyTomography, Optical CoherenceClassificationPolypoidal choroidal vasculopathyReview

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.